Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 69 citing Catherwood: Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular.... (0.09 sec) 

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

- annals.org [PDF] 
RG Hart, JL Halperin - Annals of internal medicine, 1999 - Am Coll Physicians
Atrial fibrillation is associated with a sixfold increased risk for stroke. More
than a dozen published randomized trials of anticoagulants or antiplatelet
agents for stroke preven- tion provide solid evidence on which to base ...
Cited by 218 - Related articles - BL Direct - All 5 versions

Cost of care distribution in atrial fibrillation patients: the COCAF study


JY Le Heuzey, O Paziaud, O Piot, M Ait Said, … - American Heart Journal, 2004 - Elsevier
During the follow-up period, 21 patients (3.13%) died and 210 (31.3%) patients
were hospitalized. The number of hospitalizations and deaths was significantly
higher in the group of persistent or permanent AF (PEAF) patients, as ...
Cited by 101 - Related articles - All 19 versions

Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at …

- bmj.com
G Nichol, F McAlister, B Pham, A Laupacis, B … - British Medical Journal, 2002 - heart.bmj.com
Design: Articles were identified by using a comprehensive search of English
language papers indexed in Medline from 1966 to August 2001. For the outcomes of
sinus rhythm and death, a random effects model was used to model repeated ...
Cited by 95 - Related articles - BL Direct - All 9 versions

Cost-effectiveness of rhythm versus rate control in atrial fibrillation

- annals.org [PDF] 
DA Marshall, AR Levy, H Vidaillet, E Fenwick … - Annals of internal medicine, 2004 - Am Coll Physicians
Background: Atrial fibrillation is the most common type of sustained cardiac
arrhythmia, but recent trials have identified no clear advantage of rhythm
control over rate control. Consequently, economic factors often play a role ...
Cited by 54 - Related articles - BL Direct - All 6 versions

[PDF] Moving from evidence to action


G Guyatt, R Yayward, WS Richardson, L Green, … - Users' Guides to the Medical Literature - ra.mahidol.ac.th
Page 1. Copyright © 2002 by the American Medical Association 175 1F MOVING
FROM EVIDENCE TO ACTION Gordon Guyatt, Robert Hayward ...
Cited by 49 - Related articles - All 6 versions

Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States


KS Coyne, C Paramore, S Grandy, M … - Value in Health, 2006 - ingentaconnect.com
Treatment of AF represents a significant health-care burden with the costs of
treating AF in the inpatient setting outweighing the costs of treating AF in the
office, emergency room or hospital outpatient settings. Further research is ...
Cited by 43 - Related articles - BL Direct - All 3 versions

New insights into the mechanisms and management of atrial fibrillation

- ecmaj.com
P Khairy, S Nattel - Canadian Medical Association Journal, 2002 - ecmaj.com
ATRIAL FIBRILLATION (AF) IS A COMMON CONTRIBUTOR to cardiovascular morbidity and
mortality. Two generally acceptable strategies exist for long-term AF
management, with ongoing studies comparing the overall mortality associated ...
Cited by 37 - Related articles - BL Direct - All 16 versions

Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation

- onlinejacc.org
PS Chan, S Vijan, F Morady, H Oral - Journal of the American College of Cardiology, 2006 - Elsevier
We developed a decision-analytic model to evaluate the cost-effectiveness of
LACA in 55- and 65-year-old cohorts with AF at moderate and low stroke risk.
Costs, health utilities, and transition probabilities were derived from ...
Cited by 37 - Related articles - BL Direct - All 21 versions

Atrial fibrillation: epidemiology, mechanisms, and management


J Sra, A Dhala, Z Blanck, S Deshpande, R … - Current problems in cardiology, 2000 - Elsevier
The incidence of AF, the most common sustained arrhythmia in clinical practice,
increases with age, and coronary artery disease, hypertension, and valvular
heart disease are common underlying substrates. Occasionally, however, AF ...
Cited by 30 - Related articles - BL Direct - All 2 versions

Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary …


SB Cantor, LS Elting, DV Hudson Jr, EB … - CA A Cancer Journal for Clinicians - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 28 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google